Biotech · Public company · Tampa, FL, US

Akari Therapeutics Plc

Ticker AKTX · SEC CIK 0001541157

Track this companyFree. Adds Akari Therapeutics Plc to your Dealase workspace and tells you when its record changes.

Clinical trials30 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline3

nomacopan (rVA576)Phase 3 · Bullous PemphigoidClinicalTrials.gov · fetched Nov 12, 2026
nomacopan (rVA576)Phase 3 · Thrombotic MicroangiopathiesClinicalTrials.gov · fetched Nov 12, 2026
CoversinPhase 2 · Paroxysmal Nocturnal Hemoglobinuria (PNH)ClinicalTrials.gov · fetched Nov 12, 2026

Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)PHASE3 · WITHDRAWN · started May 6, 2022ClinicalTrials.gov NCT05061771 · fetched Nov 12, 2026
Nomacopan (rVA576) in Transplant Associated Thrombotic MicroangiopathyPHASE3 · TERMINATED · started Feb 1, 2021ClinicalTrials.gov NCT04784455 · fetched Nov 12, 2026
Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 PolymorphismsPHASE2 · COMPLETED · started May 14, 2018ClinicalTrials.gov NCT03427060 · fetched Nov 12, 2026